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Background
Appropriate first-line management of anaphylaxis is
based on its recognition and application of intramuscular
adrenaline as soon as possible. Parents, other caregivers
including kindergarten and school personnel and also
children themselves are first-line actors in case of ana-
phylaxis in a child or teenager and therefore comprehen-
sive and thorough training for them is essential.
Methods
We have applied ten short questions to parents and other
caregivers (including kindergarten and school personnel)
considering ability of their anaphylaxis recognition and
management and willingness to help in case of anaphy-
laxis. The same questionnaire was used before and after
2-hour long course on recognition and management of
anaphylaxis in three allergological centers in Slovenia.
Results
138 participants were included. 75% of participants
recognised correctly signs of anaphylaxis before and 74%
after the course. Regarding the correct position during
anaphylaxis there were 77% correct answers before the
course and 99% after. The rate of correct answers about
adrenaline being the most important drug during the
anaphylaxis increased from 72% before the course to
100% afterwards. Regarding the correct order of man-
agement during the anaphylaxis there were 57% correct
answers in the pre-course questionnaire and 94% in the
post-course questionnaire. 33% of participants answered
correctly the question about the correct application of
adrenaline auto-injector Epipen before the course and
93 % after the course.
70% of participants would give adrenaline by auto-injec-
tor to the child with anaphylaxis before the course and
96% after the course. 29% of all participants were worried
about the side effects of adrenaline, 34% of all about the
legal consequences and 20% about the injury of a child
with a needle. 43% of the participants believed public
awareness campaign would contribute to better manage-
ment of anaphylaxis in children, 34% of all thought the
regulation of legislation is needed. Only 13% felt compe-
tent to help the child with anaphylaxis before the course
but after the course that percentage raised to 71%.
Conclusions
The 2-hour courses on anaphylaxis management
enhanced theoretical ability and the willingness of
appropriate first-line management of anaphylaxis in
caregivers. Recognition of symptoms and signs of ana-
phylaxis was more difficult to teach. If the adrenaline
auto-injector is prescribed to a child or teenager such
trainings should be provided.
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